FDG-PET/CT: New horizons in anal cancer

Gastroenterologie Clinique et Biologique

Volumn 33, Issue 5, 2009, Pages 456-458

  Grigsby, P W ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Washington University in St Louis School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE;

ANUS CANCER; ARTICLE; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIATION DOSE; TUMOR VOLUME; UTERINE CERVIX CANCER;

ANUS NEOPLASMS; HUMANS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67349232354     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2009.01.012     Document Type: Article

References (15)

1. Trautmann T.G., and Zuger J.H. Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal. Mol Imaging Biol 7 (2005) 309-313
2. Nguyen B.D., Ram P.C., and Roarke M.C. F-18 FDG PET/CT imaging of anal canal squamous cell carcinoma. Clin Nucl Med 32 (2007) 234-236
3. Miller T.R., and Grigsby P.W. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys 53 (2002) 353-359
4. Schwarz J.K., Siegel B.A., Dehdashti F., Myerson R.J., Fleshman J.W., and Grigsby P.W. Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer. Int J Radiat Oncol Biol Phys 71 (2007) 180-186
5. Nguyen B.T., Joon D.L., Khoo V., Quong G., Chao M., Wada M., et al. Assessing the impact of FDG-PET in the management of anal cancer. Radiother Oncol 87 (2008) 376-382
6. Cotter S.E., Grigsby P.W., Siegel B.A., Dehdashti F., Malyapa R.S., Fleshman J.W., et al. FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 720-725
7. Widder J., Kastenberger R., Fercher E., Schmid R., Langendijk J.A., Dobrowsky W., et al. Radiation dose associated with local control in advanced anal cancer: retrospective analysis of 129 patients. Radiother Oncol 87 (2008) 367-375
8. Fleshner P.R., Chalasani S., Chang G.J., Levien D.H., Hyman N.H., and Buie W.D. Practice parameters for anal squamous neoplasms. Dis Colon Rectum 51 (2008) 2-9
9. Konski A., Garcia Jr. M., John M., Krieg R., Pinover W., Myerson R., et al. Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08. Int J Radiat Oncol Biol Phys 72 (2008) 114-118
10. Glynne-Jones R., Meadows H., Wan S., Gollins S., Leslie M., Levine E., et al. EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Int J Radiat Oncol Biol Phys 72 (2008) 119-126
11. Salama J.K., Mell L.K., Schomas D.A., Miller R.C., Devisetty K., Jani A.B., et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 25 (2007) 4581-4586
12. Meyer J.J., Willett C.G., and Czito B.G. Emerging role of intensity-modulated radiation therapy in anorectal cancer. Expert Rev Anticancer Ther 8 (2008) 585-593
13. Anderson C., Koshy M., Staley C., Esiashvili N., Ghavidel S., Fowler Z., et al. PET-CT fusion in radiation management of patients with anorectal tumors. Int J Radiat Oncol Biol Phys 69 (2007) 155-162
14. Mell L.K., Schomas D.A., Salama J.K., Devisetty K., Aydogan B., Miller R.C., et al. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 70 (2008) 1431-1437
15. Schwarz J.K., Siegel B.A., Dehdashti F., and Grigsby P.W. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 298 (2007) 2289-2295